Childhood Physical Activity Levels Tied to Risk for Liver Disease in Young Adults
By Lori Solomon HealthDay Reporter
WEDNESDAY, June 19, 2024 -- Increasing physical activity during childhood may independently lower the risk for liver disease in young adulthood, according to a study published online May 29 in npj Gut and Liver.
Andrew O. Agbaje, M.D., M.P.H., Ph.D., from the University of Eastern Finland in Kuopio, used data from 2,684 children (aged 11 years) participating in the Avon Longitudinal Study of Parents and Children who had accelerometer data from at least one follow-up timepoint.
Agbaje found that the prevalence of liver steatosis was 2.6 percent at age 17 years and 20.5 percent at age 24 years. There was an association between a cumulative one-minute/day increase in sedentary time from ages 11 to 24 years and higher odds of liver cirrhosis (odds ratio [OR], 1.004) and severe liver steatosis (OR, 1.001) at age 24 years. Progressively increased alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ-glutamyl transferase (GGT) from ages 17 to 24 years was associated with increased childhood sedentary time. Lower odds of liver cirrhosis (OR, 0.990) and severe liver steatosis (OR, 0.999) at age 24 years were seen with cumulative one-minute/day light physical activity. Lower odds of severe liver steatosis (OR, 0.996) were also seen with cumulative one-minute/day moderate-to-vigorous physical activity at age 24 years. Increased fat mass significantly suppressed the effect of moderate-to-vigorous physical activity on lowering liver steatosis (64 percent suppression).
"The most effective antidote to the devastating health effects of childhood sedentariness is not the much-advertised moderate-to-vigorous physical activity of 60 minutes per day," Agbaje said in a statement. "Rather, it is the overlooked light-intensity physical activity of three to four hours per day."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.